# SOX5

## Overview
The SOX5 gene encodes the SRY-box transcription factor 5, a member of the SOX family of transcription factors, which are characterized by a conserved high-mobility group (HMG) domain. This domain is essential for the protein's ability to bind DNA and regulate transcription. SOX5 plays a pivotal role in various biological processes, including the differentiation and function of beta-cells, chondrocytes, and neurons. The protein is involved in critical pathways that influence insulin secretion, cartilage formation, and neural development. SOX5's function is mediated through its ability to form homo- or heterodimers, enhancing its DNA-binding affinity and transcriptional activity. The gene's expression and activity are regulated through alternative splicing and post-translational modifications, such as phosphorylation. Mutations in SOX5 are associated with several disorders, including Lamb-Shaffer syndrome, highlighting its clinical significance in neurodevelopmental and skeletal conditions (Lefebvre1998A; Edgerley2023SOX5:; Saravanan2024Characterization).

## Structure
The SOX5 protein is characterized by a conserved high-mobility group (HMG) domain, which is crucial for its DNA-binding capability. This domain allows SOX5 to bind to the minor groove of DNA, inducing a bend that is important for transcriptional regulation (Saravanan2024Characterization). The protein also contains coiled-coil domains that facilitate dimerization, which is essential for its function. These domains enable SOX5 to form homo- or heterodimers, and potentially tetramers, enhancing its DNA binding affinity (Lefebvre1998A; Saravanan2024Characterization).

The primary structure of SOX5 includes a sequence of amino acids that form the basis for its secondary and tertiary structures. The secondary structure of the HMG domain is predominantly alpha-helical, as revealed by circular dichroism spectroscopy (Saravanan2024Characterization). The tertiary structure is stabilized by non-polar amino acids within the coiled-coil domains, contributing to the formation of stable, four-stranded coiled-coils (Saravanan2024Characterization).

SOX5 exists in multiple isoforms due to alternative splicing, with the long form, L-Sox5, containing an additional N-terminal sequence compared to the shorter form. This long form is expressed in chondrocytes and plays a role in chondrogenesis (Lefebvre1998A). The protein can undergo post-translational modifications, such as phosphorylation, which may influence its activity (Saravanan2024Characterization).

## Function
The SOX5 gene encodes a transcription factor that plays a significant role in various cellular processes, particularly in the differentiation and function of beta-cells, chondrocytes, and neurons. In beta-cells, SOX5 is crucial for insulin secretion and glucose metabolism. It regulates the expression of genes like MafA and Pdx1, which are important for beta-cell function, and influences the activity of L-type Ca2+ channels, essential for insulin exocytosis. Reduced SOX5 expression leads to impaired glucose metabolism and decreased insulin secretion, contributing to the pathology of type 2 diabetes (Axelsson2017Sox5).

In chondrocytes, SOX5, along with SOX6 and SOX9, forms a complex that activates the type II collagen gene (Col2a1), essential for cartilage formation. This cooperative interaction is crucial for chondrocyte differentiation and cartilage maintenance (Lefebvre1998A). SOX5 also plays a role in neural development, where it is involved in the differentiation of postmitotic neurons and the generation of corticofugal neurons, contributing to neocortical neuron diversity (She2015SOX).

SOX5 is active in the nucleus, where it binds to DNA and influences gene expression, impacting cell fate and tissue development (She2015SOX).

## Clinical Significance
Mutations and alterations in the SOX5 gene are associated with several neurodevelopmental and skeletal disorders. Lamb-Shaffer syndrome (LSS) is a notable condition linked to SOX5 haploinsufficiency, characterized by developmental delays, intellectual disability, speech and language deficits, and behavioral abnormalities, including autistic traits (Zawerton2020Widening; Edgerley2023SOX5:). Dysmorphic features such as down-slanting palpebral fissures and frontal bossing are also observed in LSS (Edgerley2023SOX5:).

SOX5 mutations can lead to a range of genetic alterations, including microdeletions, point mutations, and balanced translocations, with many cases being de novo (Edgerley2023SOX5:). These genetic changes often result in haploinsufficiency, affecting the gene's normal function and leading to the clinical manifestations of LSS (Zawerton2020Widening).

In addition to LSS, SOX5 variants have been implicated in other conditions such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and intellectual disabilities (Li2017Silencing). The gene's role in neuronal development and function suggests its involvement in a broad spectrum of neurological disorders (Li2017Silencing).

## Interactions
SOX5, a member of the SOX family of transcription factors, participates in various interactions with other proteins and nucleic acids, influencing gene expression in different developmental contexts. In melanocyte development, SOX5 interacts with SOX10 by binding to melanocytic target gene promoters such as Mitf and Dct. SOX5 counteracts the transcriptional activity of SOX10, reducing its ability to activate these promoters. This interaction is characterized by SOX5's recruitment of transcriptional corepressors like HDAC1 and CtBP2 to the promoters, enhancing its inhibitory effects on SOX10-dependent activation (Stolt2008The).

In chondrogenesis, SOX5, particularly its long isoform L-SOX5, forms complexes with SOX6 and SOX9. These proteins bind to the chondrocyte-specific Col2a1 enhancer, cooperating to activate the Col2a1 gene, a marker of chondrocytes. L-SOX5 and SOX6 can dimerize through their coiled-coil domains, stabilizing their binding to DNA and enhancing transcriptional activation (Lefebvre1998A). SOX5 also interacts with CTBP2 in different models of cell differentiation, such as in the otic vesicle, where it recruits CTBP2 to repress transcription from the FGF3 promoter (Bernard2010Acquisition).


## References


[1. (Bernard2010Acquisition) Pascal Bernard and Vincent R. Harley. Acquisition of sox transcription factor specificity through protein–protein interaction, modulation of wnt signalling and post-translational modification. The International Journal of Biochemistry &amp; Cell Biology, 42(3):400–410, March 2010. URL: http://dx.doi.org/10.1016/j.biocel.2009.10.017, doi:10.1016/j.biocel.2009.10.017. This article has 72 citations.](https://doi.org/10.1016/j.biocel.2009.10.017)

[2. (Lefebvre1998A) V. Lefebvre. A new long form of sox5 (l-sox5), sox6 and sox9 are coexpressed in chondrogenesis and cooperatively activate the type ii collagen gene. The EMBO Journal, 17(19):5718–5733, October 1998. URL: http://dx.doi.org/10.1093/emboj/17.19.5718, doi:10.1093/emboj/17.19.5718. This article has 632 citations.](https://doi.org/10.1093/emboj/17.19.5718)

[3. (Stolt2008The) C. C. Stolt, P. Lommes, S. Hillgartner, and M. Wegner. The transcription factor sox5 modulates sox10 function during melanocyte development. Nucleic Acids Research, 36(17):5427–5440, August 2008. URL: http://dx.doi.org/10.1093/nar/gkn527, doi:10.1093/nar/gkn527. This article has 75 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkn527)

[4. (Li2017Silencing) Airong Li, Basavaraj Hooli, Kristina Mullin, Rebecca E. Tate, Adele Bubnys, Rory Kirchner, Brad Chapman, Oliver Hofmann, Winston Hide, and Rudolph E. Tanzi. Silencing of the drosophila ortholog of sox5 leads to abnormal neuronal development and behavioral impairment. Human Molecular Genetics, 26(8):1472–1482, February 2017. URL: http://dx.doi.org/10.1093/hmg/ddx051, doi:10.1093/hmg/ddx051. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddx051)

[5. (Zawerton2020Widening) Ash Zawerton, Cyril Mignot, Ashley Sigafoos, Patrick R. Blackburn, Abdul Haseeb, Kirsty McWalter, Shoji Ichikawa, Caroline Nava, Boris Keren, Perrine Charles, Isabelle Marey, Anne-Claude Tabet, Jonathan Levy, Laurence Perrin, Andreas Hartmann, Gaetan Lesca, Caroline Schluth-Bolard, Pauline Monin, Sophie Dupuis-Girod, Maria J. Guillen Sacoto, Rhonda E. Schnur, Zehua Zhu, Alice Poisson, Salima El Chehadeh, Yves Alembik, Ange-Line Bruel, Daphné Lehalle, Sophie Nambot, Sébastien Moutton, Sylvie Odent, Sylvie Jaillard, Christèle Dubourg, Yvonne Hilhorst-Hofstee, Tina Barbaro-Dieber, Lucia Ortega, Elizabeth J. Bhoj, Diane Masser-Frye, Lynne M. Bird, Kristin Lindstrom, Keri M. Ramsey, Vinodh Narayanan, Emily Fassi, Marcia Willing, Trevor Cole, Claire G. Salter, Rhoda Akilapa, Anthony Vandersteen, Natalie Canham, Patrick Rump, Erica H. Gerkes, Jolien S. Klein Wassink-Ruiter, Emilia Bijlsma, Mariëtte Hoffer, Marcelo Vargas, Antonina Wojcik, Florian Cherik, Christine Francannet, Jill A. Rosenfeld, Keren Machol, Daryl A. Scott, Carlos A. Bacino, Xia Wang, Gary D. Clark, Marta Bertoli, Simon Zwolinski, Rhys H. Thomas, Ela Akay, Richard C. Chang, Rebekah Bressi, Rossana Sanchez Russo, Myriam Srour, Laura Russell, Anne-Marie E. Goyette, Lucie Dupuis, Roberto Mendoza-Londono, Catherine Karimov, Maries Joseph, Mathilde Nizon, Benjamin Cogné, Alma Kuechler, Amélie Piton, Eric W. Klee, Véronique Lefebvre, Karl J. Clark, and Christel Depienne. Widening of the genetic and clinical spectrum of lamb–shaffer syndrome, a neurodevelopmental disorder due to sox5 haploinsufficiency. Genetics in Medicine, 22(3):524–537, March 2020. URL: http://dx.doi.org/10.1038/s41436-019-0657-0, doi:10.1038/s41436-019-0657-0. This article has 24 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41436-019-0657-0)

[6. (She2015SOX) Zhen-Yu She and Wan-Xi Yang. Sox family transcription factors involved in diverse cellular events during development. European Journal of Cell Biology, 94(12):547–563, December 2015. URL: http://dx.doi.org/10.1016/j.ejcb.2015.08.002, doi:10.1016/j.ejcb.2015.08.002. This article has 125 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejcb.2015.08.002)

7. (Saravanan2024Characterization) Characterization of DNA binding and oligomerization domains of stem cell transcription factor Sox9 and Sox5. This article has 0 citations.

[8. (Axelsson2017Sox5) A. S. Axelsson, T. Mahdi, H. A. Nenonen, T. Singh, S. Hänzelmann, A. Wendt, A. Bagge, T. M. Reinbothe, J. Millstein, X. Yang, B. Zhang, E. G. Gusmao, L. Shu, M. Szabat, Y. Tang, J. Wang, S. Salö, L. Eliasson, I. Artner, M. Fex, J. D. Johnson, C. B. Wollheim, J.M.J. Derry, B. Mecham, P. Spégel, H. Mulder, I.G. Costa, E. Zhang, and A. H. Rosengren. Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes. Nature Communications, June 2017. URL: http://dx.doi.org/10.1038/ncomms15652, doi:10.1038/ncomms15652. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms15652)

[9. (Edgerley2023SOX5:) Katharine Edgerley, Lisa Bryson, Lucy Hanington, Rachel Irving, Shelagh Joss, Anne Lampe, Isabelle Maystadt, Deborah Osio, Ruth Richardson, Miranda Split, Francis H. Sansbury, Ingrid Scurr, Helen Stewart, Alisdair McNeil, and Karen Low. <scp>sox5</scp>: <scp>lamb–shaffer</scp> syndrome—a case series further expanding the phenotypic spectrum. American Journal of Medical Genetics Part A, 191(5):1447–1458, March 2023. URL: http://dx.doi.org/10.1002/ajmg.a.63124, doi:10.1002/ajmg.a.63124. This article has 2 citations.](https://doi.org/10.1002/ajmg.a.63124)